Mahindra Manulife Mid Cap Growth Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹1,000

Mahindra Manulife Mid Cap Growth Direct Plan

NAV
₹36.2007
-0.36%
(29 Aug)
AUM
3,921 Cr
TER
0.46%
Risk
Very High Risk
Rating
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
Net Asset Value (NAV) is above its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+9.8%
+1.7%
+1.1%
+1.1%
-3.5%
-6.0%
3Y
+28.5%
+26.0%
+29.5%
+25.4%
+20.8%
+23.7%
5Y
+28.6%
+28.5%
+33.6%
+29.8%
+24.8%
+27.6%
ALL
+21.7%
+21.0%
+23.8%
+22.1%
+16.7%
+18.4%
VOL
16.0%
15.7%
17.6%
16.9%
-
17.2%
TER
0.6%
0.7%
0.7%
0.4%
-
0.5%
AUM
₹7,802 Cr
₹83,847 Cr
₹33,609 Cr
₹11,027 Cr
-
₹3,921 Cr
INFO
1.35
1.33
1.35
1.31
-
1.07
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
Mahindra Manulife Mid Cap (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Jul
Top holdings
Max Healthcare Institute Ltd Ordinary Shares
2.6%
Indian Bank
2.5%
Triparty Repo
2.5%
Blue Star Ltd
2.4%
Tube Investments of India Ltd Ordinary Shares
2.2%
JK Cement Ltd
2.2%
Glenmark Pharmaceuticals Ltd
2.1%
UNO Minda Ltd
2.1%
Piramal Enterprises Ltd
2.1%
Bharti Hexacom Ltd
2.1%
Top industry exposure
Financial Services
20.1%
Industrials
17.6%
Consumer Cyclical
14.8%
Healthcare
12.3%
Technology
7.7%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
61%
Lock-in period
-
Exit load
• 1% for redemption within 90 days
Fund objective
The investment objective of the Scheme is to seek to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies.
Fund manager(s)
Krishna Sanghavi
Manish Lodha
Kirti Dalvi

FAQs